Verastem, Inc. (VSTM) earnings
VSTM earnings moved a median of -0.70% by the close. Quarterly and annual VSTM reports and results, each read against the price at its own news timestamp. Back to the VSTM overview →
25 measured VSTM earnings events.
Where these VSTM earnings landedvs 24 measured VSTM earnings reactions
| Middle 50% of VSTM earnings reactions | -4.17% to +1.59% |
|---|---|
| Median reaction (to close) | -0.70% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 VSTM earnings events with a measured close landed between -4.17% and +1.59%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Verastem, Inc. For: Jun 30 | SEC filing · Form 10-Q | +3.38% | +1.35% | |
| Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates | Press release | +3.38% | +1.35% | |
| Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | +0.17% | +5.28% | |
| Form 10-Q Verastem, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.21% | -10.28% | |
| Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates | Press release | -3.21% | -10.28% | |
| Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | +0.98% | +2.30% | |
| Form 10-K Verastem, Inc. For: Dec 31 | SEC filing · Form 10-K | +6.89% | +3.36% | |
| Form 10-Q Verastem, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.16% | +0.74% | |
| Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates | Press release | -8.45% | -13.17% | |
| Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025 | Press release | -0.64% | -0.51% | |
| Form 10-Q Verastem, Inc. For: Jun 30 | SEC filing · Form 10-Q | +3.75% | +20.36% | |
| Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates | Press release | +3.75% | +20.36% | |
| Verastem Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | -0.00% | — | |
| Form 10-Q Verastem, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.82% | -4.17% | |
| Verastem Oncology Reports First Quarter 2025 Financial Results and Highlights Recent Business Updates | Press release | +2.82% | -4.17% | |
| Form 10-K Verastem, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.15% | -0.89% | |
| Form 10-Q Verastem, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.64% | -1.91% | |
| Verastem Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates | Press release | -1.64% | -1.91% | |
| Form 10-Q Verastem, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.26% | -1.26% | |
| Verastem Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Updates | Press release | -1.26% | -1.26% | |
| Form 10-Q Verastem, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.26% | +0.85% | |
| Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates | Press release | -0.26% | +0.85% | |
| Form 10-K Verastem, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.60% | +10.11% | |
| Form 10-Q Verastem, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -4.71% | |
| Verastem Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress | Press release | +0.00% | -4.71% |
Keep exploring
More VSTM: analyst actions → · SEC filings → · VSTM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Zai Lab Limited - American Depositary Shares (ZLAB) | 415 | 0.00% | 49% |
| Bausch Health Companies Inc. (BHC) | 412 | +0.06% | 50% |
| Alphatec Holdings, Inc. (ATEC) | 409 | -0.18% | 45% |
| Align Technology, Inc. (ALGN) | 407 | -0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.